Bipolar - Articles - Page 2 | CARLAT PUBLISHING

Bipolar Upgrade 6: Dark Therapy

September 11, 2023

Chris Aiken, MD and Kellie Newsome, PMHNP

Updates on dark therapy for mania from the 2023 International Bipolar Conference.

CARLAT WEBINAR

Treatment of Bipolar Disorder in Pregnant and Postpartum Women

March 10, 2023

Victoria Hendrick, MD.

0.50 CME Credits. What are the risks associated with pharmacologic treatments of bipolar disorder in pregnancy? This webinar will arm clinicians with the knowledge to prescribe (or not to prescribe) during pregnancy.

Research Update

Adjuvant Clonidine for Mania

March 8, 2023

Michael Posternak, MD.

Michael Posternak, MD. Dr. Posternak has no financial relationships with companies related to this material.

Clonidine was a promising therapy for mania in the 1980s, but the ball got dropped. This study picks that up with a modern-day randomized-controlled design.

How to Diagnose Bipolar Disorder

November 29, 2022

Chris Aiken, MD

0.50 CME Credits. Learn about six mood disorders in DSM, how to diagnose hypomania and some screening tools that can help you with that in practice.

Sorting Out Bipolar Spectrum Disorders in Children and Adolescents

November 28, 2022

Joshua Feder, MD and Mara Goverman

Bipolar disorder is challenging to diagnose in children and adolescents, yet timely and accurate diagnosis is crucial.

Antidepressants and Bipolar at the Mood Summit

November 21, 2022

Chris Aiken, MD and Kellie Newsome, PMHNP

Dr. Joe Goldberg gathered the latest evidence on antidepressants in bipolar disorder at the 9th annual Mood Disorders Summit, and we summarize his findings.

CLINICAL UPDDATE

Bipolar Spectrum Disorders in Children and Adolescents

October 30, 2022

Anthony Charuvastra, MD. Adjunct Assistant Professor, NYU Langone Medical Center Department of Child and Adolescent Psychiatry. New York, NY.

Dr. Charuvastra, author of this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.

Bipolar disorder is challenging to diagnose in children and adolescents, yet timely and accurate diagnosis is crucial.

Psychopharm Commandment 4: Lamotrigine Rash

October 24, 2022

Chris Aiken, MD and Kellie Newsome, PMHNP

How to assess, treat, and when you can restart after a lamotrigine rash.

RESEARCH UPDATE

Pediatric Bipolar Depression: How Do We Rate a New Meta-Analysis?

October 1, 2022

Sibel Algon, MD.

Dr. Algon, author of this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.

Clinicians use olanzapine, mirtazapine, and other appetite-inducing medications off label to treat ARFID, but with little research to support their use. This study unpacks the potential role of medications in treating comorbid symptoms associated with ARFID.